1 min read

Chemical Science Scotland
Scottish software firm strikes deal with global drugs giant.

Glasgow-based scientific software firm DeepMatter has today announced a tie-up with drugs giant AstraZeneca.

Under the collaboration, AstraZeneca will use DeepMatter’s DigitalGlassware platform to help accelerate its drug development work. It is the second commercial partnership to be secured by DeepMatter for the platform since it was launched earlier this year. Shares in DeepMatter rose by more than 58% after the news.

To read more, click here.